- Home
- CMPS vs BCSF Comparison
CMPS vs BCSF Comparison
Compare CMPS & BCSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMPS | BCSF |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 724.5M | 799.8M |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | CMPS | BCSF |
|---|---|---|
| Price | $5.76 | $13.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $26.57 | $14.00 |
| AVG Volume (30 Days) | ★ 1.8M | 460.9K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 15.35% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.53 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.25 | $11.82 |
| 52 Week High | $8.90 | $16.00 |
Technical Indicators
Market Signals| Indicator | CMPS | BCSF |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 61.62 |
| Support Level | $4.90 | $11.92 |
| Resistance Level | $7.02 | $14.53 |
| Average True Range (ATR) | 0.28 | 0.29 |
| MACD | 0.07 | 0.10 |
| Stochastic Oscillator | 71.76 | 100.00 |
Price Performance
Historical ComparisonAbout CMPS COMPASS Pathways Plc American Depository Shares
Compass Pathways PLC is a biotechnology company focused on developing therapies for mental health conditions. Its research centers on a proprietary synthetic psilocybin formulation, COMP360, which is administered alongside psychological support. The company is conducting clinical trials to evaluate the safety and efficacy of this treatment in patients with treatment-resistant depression and other mental health disorders. The company operates in one operating segment.
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing in middle-market companies. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan, and others.